Lilly was founded in 1876 by Colonel Eli Lilly, a man committed to creating high-quality medicines that met real needs in an era of unreliable elixirs peddled by questionable characters. His charge to the generations of employees who have followed was this: "Take what you find here and make it better and better."

healthcare company Eli Lilly and Co (Lilly) is a healthcare company that is engaged in the discovery, development, and marketing of human healthcare products.

As of 2022, Lilly is known for its clinical depression drugs Prozac (fluoxetine) (1986), Cymbalta (duloxetine) (2004), and its antipsychotic medication Zyprexa (olanzapine) (1996), although its primary revenue drivers are the diabetes drugs Humalog (insulin lispro) (1996) and Trulicity (dulaglutide) (2014).

U.S.A. Headquarters located in Indianapolis, Indiana, U.S.A.

Lilly was among the first companies to develop a method to mass-produce Penicillin-G, the world's first widely available antibiotic, marking the beginning of a sustained effort to fight infectious diseases.

Eli Lilly and Company has an overall rating of 4.0 out of 5, based on over 4,663 reviews left anonymously by employees. 79% of employees would recommend working at Eli Lilly and Company to a friend and 82% have a positive outlook for the business. This rating has been stable over the past 12 months.

Trulicity Trulicity remains the company's top drug -- for now Diabetes drug Trulicity generated more than $7.4 billion in revenue for Eli Lilly last year, accounting for more than one-quarter of the company's top line, which totaled $28.5 billion.

The company sees the expected 2023 launches of donanemab, pirtobrutinib, mirikizumab and lebrikizumab as major growth drivers, along with its 2022 diabetes launch Mounjaro.

Eli Lilly's Mounjaro, cleared for type 2 diabetes and awaiting FDA approval for weight loss, targets both GLP-1 and a hormone called GIP, and has produced weight loss of 21 to 23%.

Trulicity remains the company's top drug -- for now However, there are a couple of fast-growing drugs that are starting to close the gap, including breast cancer drug Verzenio and diabetes drug Mounjaro, both of which generated more than $900 million in sales for the period. Image source: company filings.

Forbes Lists

• #140. World's Best Employers (2023) Drugs & Biotechnology.
• #201. Global 2000 (2023) #450 - SALES.
• #10. Net Zero Leaders (2023) Pharmaceuticals.
• #53. World's Top Female-Friendly Companies (2022)
• #8. Green Growth Companies (2021)
• #58. Just Companies (2021)
• #232. America's Largest Public Companies (2018)

Lilly was among the first companies to develop a method to mass-produce Penicillin-G, the world's first widely available antibiotic, marking the beginning of a sustained effort to fight infectious diseases.